Max Robotics — Global Service Robot Directory + US Certification

About

Alfio Ferlito is a leading figure in head and neck surgical oncology, with a career dedicated to advancing minimally invasive approaches and refining management strategies for complex aerodigestive tract malignancies. His research has been instrumental in defining the role of transoral robotic surgery (TORS), particularly in establishing clear contraindications for oropharyngeal cancer and demonstrating its potential as a single-modality therapy to reduce the toxicity of chemoradiation. Ferlito’s work on neck cancer of unknown primary (NCUP) has been pivotal in the HPV era, providing comprehensive frameworks for diagnosis and treatment. He has also critically examined the evolving landscape of open surgery, arguing that despite the rise of minimally invasive techniques, it remains essential for salvage procedures and complex cases. With over 270 citations across his most-cited papers, his contributions have shaped clinical guidelines and surgical decision-making worldwide. Notably, his exploration of remote-access thyroidectomy in pediatric populations and benign nerve sheath tumors highlights his commitment to expanding surgical frontiers while prioritizing patient outcomes. Ferlito’s legacy lies in bridging innovation with evidence-based practice, ensuring that technological advances serve the fundamental goal of improving survival and quality of life for head and neck cancer patients.